Effects of Routine Physical Therapy With and Without Proprioceptive Neuromuscular Facilitation on Balance, Gait and Function in Patients With Parkinson's Disease
1 other identifier
interventional
38
1 country
2
Brief Summary
Objective of this study is to compare the effectiveness of routine physical therapy with and without Proprioceptive Neuromuscular Facilitation on Balance, gait and function in patients with Parkinson's disease. Alternate hypothesis: There will be a difference in the effects of routine physical therapy with and without proprioceptive neuromuscular facilitation on balance, gait and function in patients with Parkinson's disease. Null hypothesis: There will be no difference in the effects of routine physical therapy with and without proprioceptive neuromuscular facilitation on balance, gait and function in patients with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Nov 2021
Shorter than P25 for not_applicable parkinson-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2021
CompletedFirst Submitted
Initial submission to the registry
November 27, 2021
CompletedFirst Posted
Study publicly available on registry
December 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2022
CompletedMarch 18, 2022
March 1, 2022
4 months
November 27, 2021
March 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Berg balance scale (BBS) (to access the change in ability to balance in individuals at baseline, 6th and 12th week of interventions.)
It is used to objectively determine a patient's ability or inability to safely balance during a series of predetermined tasks. It consist of a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4.0 denotes inability to complete the item, and 4 the ability to accomplish the task. Scores of less than 45 out of 56 are accepted as indicative of balance disorders in the elderly.
the change in ability to balance in individuals at baseline, 6th and 12th week of interventions.
The Freezing of Gait Questionnaire (FOGQ) (to access the change in freezing of gait in individuals at baseline, 6th and 12th week.)
It is used to assess freezing of gait severity in patients with Parkinson's disease. It consists of a 6-item questionnaire. A 5-point scale is used to mark scores. Zero (absence of symptoms) to 4 (most severe), is used for each item to rank severity of symptoms.
the change in freezing of gait in individuals at baseline, 6th and 12th week
Functional Independence Measure (FIM) (to assess the change in ability to do activities of daily living at baseline, 6th and 12th week.)
It is used to assess the ability of patients to do activities of daily living. It consist of 18-item, clinician-reported scale that assesses function in six areas including self-care, continence, mobility, transfers, communication, and cognition. Total score for FIM will be a value between 18 and 126. Higher the score, more independent the patient is.
the change in ability to do activities of daily living at baseline, 6th and 12th week
Study Arms (2)
group A/ routine physical therapy and PNF
EXPERIMENTALIn group A, PNF based gait training (15 minutes) and conventional physical therapy (45 minutes) will be performed. PNF exercises involved PNF pelvic patterns (pelvic interior elevation and posterior depression), PNF lower extremity D1 Flexion and PNF lower extremity D1 extension (Unilateral during 1st to 3rd week and bilateral from 4th week onwards). Exercises will progress from rhythmic initiation and then progress to slow reversal and agonistic reversal up to 6th week of therapy and continues until 12th week. Each exercise will be repeated for 10 to 20 times. Conventional physiotherapy will be administered according to the European Physiotherapy guidelines for Parkinson's disease. Other exercises include: 1. Range of motion exercises 2. Stretching exercises 3. Upper and lower limb strengthening exercises
group B/ routine physical therapy
ACTIVE COMPARATORConventional physical therapy (45 minute session) will be performed in group B.Conventional physiotherapy will be administered according to the European Physiotherapy guidelines for Parkinson disease. Other exercises include: 1. Range of motion exercises 2. Stretching exercises 3. Upper and lower limb strengthening exercises
Interventions
Proprioceptive Neuromuscular Facilitation (PNF) is a more advanced form of flexibility training, which involves both the stretching and contracting of the muscle group being targeted. PNF stretching is one of the most effective forms of stretching for improving flexibility and increasing range of motion.
Routine physiotherapy in Parkinson Disease will be administered according to the European Physiotherapy guidelines for Parkinson Disease and focused on the following areas based on the stage of the disease:Self-management support, prevention of inactivity and fear of falls, maintaining or improving global motor activities, improvement of physical performance, and improvement in the ability to perform transfer, balance, gait, and manual activities, reduce pain, and delay the onset of physical limitations. Other exercises include: 1. Range of motion exercises 2. Stretching exercises 3. Upper and lower limb strengthening exercises
Eligibility Criteria
You may qualify if:
- Male and female patients of age between 60 and 85 years, diagnosed with Parkinson's disease by a neurologist.
- Patients with Hoehn and Yahr stages 1-3.
- Patients with a stable drug program and acclimated to their current medication use for at least 2 weeks.
You may not qualify if:
- Cognitive deficits (scores of \<26 on the Mini-Mental State Examination).
- Moderate or severe depression (scores of \>17 on the Beck Depression Inventory).
- Patients with neurological diseases, arthrosis, or total hip joint replacement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sir Ganga Raam Hospital
Lahore, Punjab Province, 75500, Pakistan
University of Lahore Teaching Hospital
Lahore, Punjab Province, 75500, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tahzeeb Mazhar, MSPTN
University of Lahore, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2021
First Posted
December 13, 2021
Study Start
November 5, 2021
Primary Completion
March 3, 2022
Study Completion
March 3, 2022
Last Updated
March 18, 2022
Record last verified: 2022-03